glp 1 chronic kidney disease SGLT2 vs GLP-1 for CKD: Which Is Better? Potential kidney-protective and other effects

Un nuevo frmaco oral basado en un receptor de GLP-1, conocido como elecoglipron, ha probado su eficacia en la fase 2B de un ensayo para reducir tanto los niveles de azcar en sangre en personas con diabetes tipo 2 como el peso corporal El nuevo medicamento, presentado este lunes en la sesin cientfica del encuentro de la Asociacin Americana de Diabetes y recogido por la revista The Lancet, ha sido desarrollado por la farmacutica AstraZneca

Imagine running a water purifier continuously at maximum pressure for years

Those risks include gestational diabetes, preeclampsia and cesarean births (C-sections)

6

Nothing in this article is medical advice, a diagnosis, or individualized healthcare guidance

As good clinical practice, ensuring that thyroid function is adequately controlled with levothyroxine before initiating additional therapies is advisable